Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study-Reference-Cited by-同舟云学术

Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study

Published:2021-03-09 Issue: Volume: Page:1-10
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Gáspár Krisztián¹²^ORCID,Hunor Gergely L.³^ORCID,Jenei Balázs⁴^ORCID,Wikonkál Norbert³^ORCID,Kinyó Ágnes⁵,Szegedi Andrea¹²^ORCID,Remenyik Éva¹^ORCID,Kiss Norbert³^ORCID,Jin Xiang⁶⁷^ORCID,Sárdy Miklós³^ORCID,Beretzky Zsuzsanna⁸⁹,Péntek Márta⁹¹⁰^ORCID,Gulácsi László⁹¹⁰^ORCID,Bánvölgyi András³,Brodszky Valentin⁹^ORCID,Rencz Fanni⁹¹¹^ORCID

Affiliation:

1. Departments of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary

2. Department of Dermatological Allergology, Faculty of Medicine, University of Debrecen, . Debrecen, Hungary

3. Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary

4. Quality of Life Statistics Department, Earnings Statistics Section, Hungarian Central Statistical Office, Budapest, Hungary

5. Medical School Department of Dermatology, Venereology and Oncodermatology, University of Pécs, Pécs, Hungary

6. Corvinus University of Budapest, Budapest, Hungary

7. School of Slavonic and East European Studies, University College London, London, The United Kingdom

8. Doctoral School of Business and Management, Corvinus University of Budapest, Budapest, Hungary

9. Department of Health Economics, Corvinus University of Budapest, Budapest, Hungary

10. Health Economics Research Center, University Research and Innovation Center, Óbuda University, Budapest, Hungary

11. Hungarian Academy of Sciences, Premium Postdoctoral Research Programme, Budapest, Hungary

Funder

co-financed by the European Union, the European Regional Development Fund, and the European Social Fund

the Higher Education Institutional Excellence Program 2020 of the Ministry for Innovation and Technology in Hungary in the framework of the ‘Financial and Public Services’

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2021.1895753

Reference64 articles.

1. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life

2. Hidradenitis suppurativa

3. Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice

4. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

5. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐World‐Effektivität und Sicherheit der LAight‐Therapie bei Patienten mit Hidradenitis suppurativa;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-07

2. Real‐world effectiveness and safety of the LAight‐therapy in patients with hidradenitis suppurativa;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-05-28

3. The impact of hidradenitis suppurativa on work productivity and performance: a systematic review and meta-analysis;Clinical and Experimental Dermatology;2024-04-09

4. Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes;Dermatology and Therapy;2024-01

5. A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective;Journal of Dermatological Treatment;2023-11-27